ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $212,000 | -55.7% | 6,325 | -64.8% | 0.02% | -39.3% |
| Q3 2016 | $479,000 | +111.0% | 17,986 | +186.0% | 0.03% | +100.0% |
| Q3 2015 | $227,000 | -74.3% | 6,289 | -68.0% | 0.01% | -72.0% |
| Q2 2015 | $884,000 | -2.3% | 19,655 | -33.5% | 0.05% | -9.1% |
| Q1 2015 | $905,000 | +166.2% | 29,546 | +342.2% | 0.06% | +96.4% |
| Q4 2014 | $340,000 | -51.8% | 6,681 | -62.5% | 0.03% | -41.7% |
| Q3 2014 | $705,000 | – | 17,808 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |